InflaRx (IFRX) EBIT Margin (2022 - 2025)
Historic EBIT Margin for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to 9478.14%.
- InflaRx's EBIT Margin rose 29270900.0% to 9478.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 25034.91%, marking a year-over-year increase of 82196800.0%. This contributed to the annual value of 31973.69% for FY2024, which is 392084400.0% up from last year.
- Per InflaRx's latest filing, its EBIT Margin stood at 9478.14% for Q3 2025, which was up 29270900.0% from 32760.16% recorded in Q2 2025.
- Over the past 5 years, InflaRx's EBIT Margin peaked at 2308149.41% during Q4 2024, and registered a low of 582075.02% during Q4 2023.
- Over the past 4 years, InflaRx's median EBIT Margin value was 9478.14% (recorded in 2025), while the average stood at 86662.83%.
- As far as peak fluctuations go, InflaRx's EBIT Margin plummeted by 2000000000bps in 2023, and later surged by 2000000000bps in 2024.
- InflaRx's EBIT Margin (Quarter) stood at 208.55% in 2022, then tumbled by -279005bps to 582075.02% in 2023, then surged by 497bps to 2308149.41% in 2024, then tumbled by -100bps to 9478.14% in 2025.
- Its EBIT Margin stands at 9478.14% for Q3 2025, versus 32760.16% for Q2 2025 and 36088.3% for Q1 2025.